NCT06381362 Italian Registry of Minimally Invasive Pancreatic Surgery
| NCT ID | NCT06381362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Associazione Italiana per lo Studio del Pancreas |
| Condition | Pancreatic Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,300 participants |
| Start Date | 2019-02-28 |
| Primary Completion | 2029-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,300 participants in total. It began in 2019-02-28 with a primary completion date of 2029-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years; * Underwent minimally invasive pancreatic surgery Exclusion Criteria: * Pregnant woman * Minor or unable to give informed consent
Contact & Investigator
Alessandro Zerbi, Prof.
PRINCIPAL INVESTIGATOR
Humanitas Research Hospital IRCCS, Rozzano-Milan
Frequently Asked Questions
Who can join the NCT06381362 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatic Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06381362 currently recruiting?
Yes, NCT06381362 is actively recruiting participants. Contact the research team at alessandro.zerbi@hunimed.eu for enrollment information.
Where is the NCT06381362 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06381362 clinical trial?
NCT06381362 is sponsored by Associazione Italiana per lo Studio del Pancreas. The principal investigator is Alessandro Zerbi, Prof. at Humanitas Research Hospital IRCCS, Rozzano-Milan. The trial plans to enroll 2,300 participants.